Evidence map›Paper›PMID 41981834›Full record

Observational studyJournal of cardiovascular electrophysiology2026

A Comprehensive Assessment of Renal Function During and After Pulsed Field Ablation.

Václav Melenovský, Marek Hozman, Sabri Hassouna, Ivana Fišerová, Barbora Bačová, Dalibor Heřman, Jakub Karch, Jana Veselá, Michal Zuzčák, Ivan Rychlík and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Václav MelenovskýDepartment of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0009-0009-7831-0352
Marek HozmanDepartment of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Sabri HassounaDepartment of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Ivana FišerováDepartment of Biochemistry and Molecular Biology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Barbora BačováDepartment of Laboratory Hematology, Central Laboratories, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Prague, Czech Republic.ORCID 0000-0003-0029-2157
Dalibor HeřmanDepartment of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0002-7436-1154
Jakub KarchDepartment of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Jana VeseláDepartment of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Michal ZuzčákDepartment of Biochemistry and Molecular Biology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Ivan RychlíkDepartement of Internal Medicine, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Pavel OsmančíkDepartment of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.

Funding

Institutional Support of Charles University, Prague
6 · The paper itself

Abstract

backgroundAcute kidney injury is an uncommon complication of pulsed field ablation (PFA). There is, however, limited empirical data on the dynamics of renal biomarkers apart from creatinine. Furthermore, no study to date has assessed creatinine at more than 24 h after the procedure.

methodsPatients undergoing PFA for atrial fibrillation (AF) were enrolled in a prospective observational study. The ablation was performed using the Farawave pentaspline catheter along with the Farapulse system and consisted of pulmonary vein isolation along with additive lesions in patients with persistent AF and/or atrial flutter. Administration of 500-1000 mL of crystalloid was a mandatory part of the periprocedural management protocol. Before and 24 h after the procedure, serum renal biomarkers were measured (urea, creatinine, cystatin C, NGAL, and KIM-1), and urinalysis was performed. Hemolysis indices (haptoglobin, Lactate Dehydrogenase, and red blood cell microparticles) were measured after the procedure. Patients were instructed to undergo blood sampling for creatinine and urea 48 h after the procedure.

resultsSamples from 88 patients were analyzed (mean age 67 ± 8.8 years, 33% female, 53% paroxysmal AF, average of 63 [IQR: 40-77] applied pulses). The creatinine concentration at 24 h decreased from 86 (IQR: 72-100) to 82 (IQR: 68-92) µmol/L (p < 0.001), the concentration at 48 h was similar to preprocedural values (83 [IQR: 69-100] µmol/L; (p = 1.00). However, 9 patients (10.2%) met AKI criteria; in six of them, AKI was only detectable at the 48-h measurement. Serum cystatin-C levels remained unchanged, and urea and urinary erythrocytes increase significantly from baseline to 24 h. NGAL levels increased significantly from 121 (IQR: 86-173) to 143 (IQR: 112-198) at 24 h while changes in KIM-1 were unsignificant. All changes in renal function were transient and did not require hospitalization. Logistic regression identified age and the total number of pulsed field pulses as the major risk factors for AKI.

conclusionsRoutine PFA with periprocedural hydration and an average of 63 PF pulses appears safe in patients without significant preexisting renal disease, with a low risk of clinically relevant renal impairment. However, the incidence of AKI in our cohort was higher than previously reported, suggesting that transient kidney function changes may be more common than recognized. These findings highlight the need for kidney function monitoring beyond 24 h in higher-risk patients undergoing PFA.

Indexed as

Acute Kidney InjuryAtrial FibrillationCatheter AblationKidneyPulmonary VeinsAgedBiomarkersCreatinineFemaleHumansIrreversible Electroporation TherapyKidney Function TestsMaleMiddle AgedPredictive Value of TestsProspective StudiesBiomarkersCreatinineUreaacute kidney injuryatrial fibrillationcatheter ablationhemepulsed‐field ablation

Identifiers

PMID41981834
PMCPMC13269865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.